A61K8/738

ANTIPERSPIRANT AND DEODORANT COMPOSITIONS

The present application relates to antiperspirant compositions comprising nitrogen-based and/or oxygen based perfume raw materials, and methods for making and using the antiperspirant compositions.

CYCLODEXTRIN-BASED ETHYL LAUROYL ARGINATE (LAE) CLATHRATE, AND PREPARATION METHOD AND USE THEREOF

A cyclodextrin-based ethyl lauroyl arginate (LAE) clathrate, and a preparation method and use thereof, belonging to the technical field of food and cosmetic additives. In the clathrate, a cyclodextrin compound is clathrated on the outside of an LAE compound to form a steric hindrance effect. In this way, the interaction between head-end cations of the LAE compound and anion substances is reduced, thereby significantly improving an antibacterial performance of the LAE compound. Moreover, the clathrate has a special structure in which a head is hydrophilic, a tail is hydrophobic, an outer wall of a cavity of the cyclodextrin compound is hydrophilic, and an inner wall of the cavity of the cyclodextrin compound is hydrophobic. This significantly improves an emulsification performance and a low-temperature solubility of the LAE compound, and reduces a self-aggregation effect of the LAE compound. Therefore, the clathrate has excellent thermal stability, acid-base stability, and low-temperature storage stability, and shows desirable application prospects in food and cosmetics.

Composition for preventing or alleviating periodontal diseases, containing, as active ingredient, mangosteen extract or α- or γ-mangosteen

The present invention provides a composition for preventing, improving or treating periodontal diseases comprising extract of mangosteen. The composition of the present invention has excellent anti-bacterial and anti-inflammatory effects against bacteria inducing periodontal diseases as comprising extract of mangosteen, or alpha-mangosteen or gamma-mangosteen derived from thereof, and thereby it can be widely used for medicines and foods for preventing, improving or treating periodontal diseases.

PERFUME COMPOSITIONS
20180193235 · 2018-07-12 ·

A compacted perfume composition comprising at least three Performance Markers A1, each of them at a level higher than or equal to their specific Critical Compaction Concentration (CCC), respectively, the total concentration of said Performance Markers being higher than 1% by weight of the compacted perfume composition; at least one Performance Vehicle A2, the total concentration of said Performance Vehicle being higher than 10% by weight of the compacted perfume composition; and at least one Performing Diluent B1, the total concentration of said Performing Diluents being higher than 5% by weight of the compacted perfume composition.

DEODORANT COMPOSITION COMPRISING A MIXTURE OF ALPHA, BETA, AND GAMMA CYCLODEXTRIN

This invention relates to an odour-absorbing composition comprising a mixture of -, -, and -cyclodextrins, wherein the amount of one of said -, -, and -cyclodextrins is equal to or higher than the total amount of the other two cyclodextrins.

Perfume systems

The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. Such perfume raw materials and compositions, including the delivery systems, disclosed herein expand the perfume communities' options as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.

Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both

A method for screening compounds and compositions that reduce cetyl pyridinium chloride activation of TRPA1 receptor or TRPV1 receptor.

Anhydrous solid composition based on particles encapsulating a beneficial agent

Provided is a solid anhydrous composition that comprises particles comprising a core containing at least one beneficial agent and an envelope surrounding the core. The envelope comprises at least one hydrophobically modified polysaccharide and at least one water-soluble carbohydrate and/or water-soluble polyol. The particles simultaneously have a poured powder density ranging from 300.0 g/l to 600.0 g/l and an absolute density of greater than 1.0. The envelope also comprises at least one structuring agent. Also provided is a cosmetic process for caring for and/or for the hygiene of and/or for conditioning and/or for fragrancing and/or for making up keratin material. The process comprises applying to the keratin material the above composition. Also provided is a cosmetic process for treating body odor and optionally human perspiration, which comprises applying to a keratin material a composition defined above comprising at least one deodorant and/or antiperspirant in free form and/or in encapsulated form.

PERSONAL CARE COMPOSITIONS

Aerosolized compositions including a cyclic oligosaccharide; a fragrance; a volatile solvent; and a propellant; wherein the aerosolized composition is free of nonvolatile solvents are described herein. The aerosolized compositions and methods disclosed herein may provide a longer lasting fragrance.

COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME
20180133274 · 2018-05-17 ·

Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described. The compositions and methods are useful in reducing appearance of facial redness in rosacea-prone skin, rejuvenating skin, preventing skin aging, inhibiting oxidative stress in epidermal and dermal cells, increasing collagen production, reducing the likelihood of skin cancer, treating or reducing liver damage from a toxin, or treating a liver disease.